TrialBritish journal of cancer1994

A phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in the intensification of cisplatin and cyclophosphamide chemotherapy for advanced ovarian cancer.

S Kehoe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.